In vitro and in vivo performance of a multiparticulate pulsatile drug delivery system

Drug Development and Industrial Pharmacy

Volumn 33, Issue 2, 2007, Pages 113-119

  Mohamad, A ^a   Dashevsky, A ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Aquacoat ECD; Aqueous coating; Crosscarmelose sodium; Pulsatile drug release

Indexed keywords

CHLORIDE; CROSCARMELLOSE SODIUM; DODECYL SULFATE SODIUM; ETHYL CELLULOSE; HYDROXYPROPYLCELLULOSE; LUTROL; METHYLCELLULOSE; PARACETAMOL; PHOSPHATE; SODIUM CHLORIDE; SUGLETS; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OUTER MEMBRANE; PH MEASUREMENT; PULSATILE DRUG RELEASE; ROTATION; SALIVA ANALYSIS; SOLUBILITY;

ACETAMINOPHEN; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOPOLYMERS; CARBOXYMETHYLCELLULOSE; CELLULOSE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; SALIVA; SODIUM CHLORIDE; SODIUM DODECYL SULFATE; TABLETS; TIME FACTORS; WATER;

EID: 34147166581     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601085433     Document Type: Article

References (21)

1. Bechgaard, H., & Nielson, G. H. (1978). Controlled release multiple units and single-unit doses. Drug Development and Industrial Pharmacy, 4, 53-67.
2. Bussemer, T., Otto, I., & Bodmeier, R. (2001). Pulsatile drug-delivery systems. Critical Reviews in Therapeutic Drug Carrier Systems, 18, 433-458.
3. Bussemer, T., Dashevsky, A., & Bodmeier, R. (2003a). A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. Journal of Controlled Release, 93, 331-339.
4. Bussemer T., & Bodmeier, R. (2003a). Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles. International Journal of Pharmaceutics, 267, 59-68.
5. Bussemer, T., Peppas, N. A., & Bodmeier, R. (2003b). Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. European Journal of Pharmaceutics & Biopharmaceutics, 56, 261-270.
6. Drobitch R. K., & Stevensen, C. K. (1992). Therapeutic drug monitoring in saliva. Clinical Pharmacokinetics. 23, 365-379.
7. Gazzaniga, A., Sangalli, M. E., & Giordano, F. (1994a). Oral Chronotopic drug delivery systems: achievement of time and/or site specificity. European Journal of Pharmaceutics & Biopharmaceutics, 40, 246-250.
8. Gazzaniga, A., Iamartino, P., Maffione, G., & Sangalli, M. E. (1994b). Oral delayed-release system for colonic specific delivery. International Journal of Pharmaceutics, 108, 77-83.
9. Galia, E., Nicholaides, E., Hörter, D., Löbenberg, Rv Reppas, C., & Dressman, J. B. (1998). Evaluation of various dissolution media for prediction in vivo performance of Class I and II drugs. Pharmaceutical Research, 15, 698-705.
10. Ghebre-Sellassie, I. (1994). Multiparticulate Oral Drug Delivery. Marcel Dekker, New York.
11. Hata, T., Shimazaki, Y., Kagayama, A., Tamura, S., & Ueda, S. (1994). Development of a novel drug release system (TES): V. Animal pharmacodynamic study and human bioavailability study. c. 110, 1-7.
12. Hirtz, J. (1985). The gastrointestinal absorption of drugs in man: A review of current contents and methods of investigation, British Journal of Clinical Pharmacology, 19, 77-83.
13. Lemmer, B. (1991). Circadian rhythms and drug delivery, Journal of Controlled Release, 16, 63-74.
14. Malamud, D., & Tabak, L. (1993). Saliva as a Diagnostic Fluid; Vol. 694, Annals of the New York Academy of Sciences, New York.
15. McConville, J. T., Ross, A. C., Florence, A. J., & Stevens, H. N. E. (2005). Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device. Drug Development and Industrial Pharmacy, 31, 79-89.
16. Mohamad, A., & Dashevsky, A. (2006). Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat® ECD. International Journal of Pharmaceutics, 318, 124-131.
17. Murata, S., Ueda, S., Shimojo, F., Tokunaga, Yv Hata, T., & Ohnishi, N. (1998). In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs. International Journal of Pharmaceutics. 161, 161-168.
18. Sungthongjeen S., Puttipipatkhachorn, S., Paeratakul, O., Dashevsky, A., & Bodmeier,R. (2004). Development of pulsatile release tablets with swelling and rupturable layers. Journal of Controlled Release, 95, 147-159.
19. Ueda, S., Ibuki, R., Kimura, S., Murata, S., Takahashi, T., & Tokunaga, Y. Hata, T. (1994). Development of a novel drug release system, time-controlled explosion system (TES). III. Relation between lag time and membrane thickness. Chemical & Pharmaceutical Bulletin, 42, 364-367.
20. Wesseling, M., & Bodmeier, R. (1999). Drug release from beads coated with aqueous colloidal ethylcellulose dispersion, Aquacoat, or an organic ethylcellulose solution, European Journal of Pharmaceutics & Biopharmaceutics, 47, 33-38.
21. Wilding, I. R., Davis, S. S., Bakhshaee, M., Stevens, H. N. E., Sparrow, R. A., & Brennan, J. (1992). Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation, Pharmaceutical Research. 9, 654-657.